false 0001533615 0001533615 2024-05-15 2024-05-15 0001533615 us-gaap:CommonStockMember 2024-05-15 2024-05-15 0001533615 us-gaap:SeriesAPreferredStockMember 2024-05-15 2024-05-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 6, 2024 (May 15, 2024)

 

Global Medical REIT Inc.

(Exact name of registrant as specified in its charter)

 

Maryland 001-37815 46-4757266
(State or other jurisdiction
of incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)

 

7373 Wisconsin Avenue, Suite 800

Bethesda, MD

20814

(Address of principal executive offices)

(Zip Code)

 

(202) 524-6851

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbols:   Name of each exchange on which registered:
Common Stock, par value $0.001 per share   GMRE   NYSE
Series A Preferred Stock, par value $0.001 per share   GMRE PrA   NYSE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

  

Explanatory Note

 

This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed by Global Medical REIT Inc. (the “Company”) with the United States Securities and Exchange Commission (the “Commission”) on May 16, 2024 (the “Original Form 8-K”). The Original Form 8-K reported the final voting results of the matters voted on at the Company’s 2024 annual meeting of stockholders held on May 15, 2024 (the “Annual Meeting”). The sole purpose of this Amendment is to disclose the Company’s decision as to the frequency of future stockholder advisory votes regarding the compensation of the Company’s named executive officers. Except as set forth herein, no other modifications have been made to the Original Form 8-K.

 

  Item 5.07 Submission of Matters to a Vote of Security Holders.

 

As previously disclosed in the Original Form 8-K, in an advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers held at the Annual Meeting, 34,040,745 shares voted for every year, 158,991 shares voted for every two years, 1,098,203 shares voted for every three years, 566,323 shares abstained and there were 13,706,822 broker non-votes. In accordance with these results and its previous recommendation (as set forth in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Commission on April 1, 2024 ), the Company’s Board of Directors has determined that the Company will hold future say-on-pay votes every year.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Global Medical REIT Inc.
   
 By:/s/ Jamie A. Barber
  Jamie A. Barber
  Secretary and General Counsel
   
Date: June 6, 2024  

 

 

v3.24.1.1.u2
Cover
May 15, 2024
Document Information [Line Items]  
Document Type 8-K/A
Amendment Flag false
Document Period End Date May 15, 2024
Entity File Number 001-37815
Entity Registrant Name Global Medical REIT Inc.
Entity Central Index Key 0001533615
Entity Tax Identification Number 46-4757266
Entity Incorporation, State or Country Code MD
Entity Address, Address Line One 7373 Wisconsin Avenue
Entity Address, Address Line Two Suite 800
Entity Address, City or Town Bethesda
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20814
City Area Code 202
Local Phone Number 524-6851
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol GMRE
Security Exchange Name NYSE
Series A Preferred Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Series A Preferred Stock, par value $0.001 per share
Trading Symbol GMRE PrA
Security Exchange Name NYSE
Global Med REIT (NYSE:GMRE)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Global Med REIT.
Global Med REIT (NYSE:GMRE)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Global Med REIT.